Fmoc-Asp(OcHex)-OH
Nα-Fmoc-L-aspartic acid β-cyclohexyl ester; (2S)-4-cyclohexyloxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid
An aspartic acid derivative whose side-chain ester was designed to suppress aspartimide formation. The secondary cyclohexyl ester is more hindered than a benzyl or methyl ester, and it was introduced for aspartyl peptides precisely because it cyclizes to the aspartimide far less readily under both the acidic and the basic treatments of a synthesis.
It is an acid-stable, Boc/benzyl-compatible group: unaffected by piperidine and by TFA, and removed by anhydrous HF or trifluoromethanesulfonic acid, the conditions of a Boc final deprotection. With Nα-Fmoc, this derivative serves Fmoc or hybrid syntheses: in an Fmoc/tBu synthesis the peptide is therefore released with the side chain still esterified, which is useful when that is wanted and a drawback otherwise; where the side chain is to come off with the peptide and aspartimide is the worry, Fmoc-Asp(OtBu)-OH with 0.1 M HOBt in the piperidine solution, or a bulkier tert-alkyl ester, is the usual route.
Applications
Storage
Store refrigerated (2–8 °C) in a tightly closed container, and let it reach room temperature before opening.
References
For research use only. Not for human or veterinary use.
| Catalog Number | 41061 |
|---|---|
| CAS | 130304-80-2 |
| M.W. | 437.48 |
| Formula | C25H27NO6 |
| IUPAC Name | (2S)-4-cyclohexyloxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid |
| InChIKey | OCMZRMNYEXIKQI-QFIPXVFZSA-N |
| InChI | InChI=1S/C25H27NO6/c27-23(32-16-8-2-1-3-9-16)14-22(24(28)29)26-25(30)31-15-21-19-12-6-4-10-17(19)18-11-5-7-13-20(18)21/h4-7,10-13,16,21-22H,1-3,8-9,14-15H2,(H,26,30)(H,28,29)/t22-/m0/s1 |
| SMILES | C1CCC(CC1)OC(=O)C[C@@H](C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24 |
The current Safety Data Sheet for Fmoc-Asp(OcHex)-OH (Catalog No: 41061).
The Certificate of Analysis for each lot of Fmoc-Asp(OcHex)-OH (Catalog No: 41061). Enter the lot number printed on the product label.